Shuyong Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shuyong Liu has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Fangfei Liu
Department of Nuclear Medicine, The Second Affiliated Hospital of Shandong First Medical University, Taian and
3 shared publicationsJianpeng Liu
Department of Radiology, Huashan Hospital, Fudan University, Shanghai
3 shared publications- Ji Xiong
Department of Pathology, Huashan Hospital, Fudan University, Shanghai, China
2 shared publications Min Li
Department of Radiology, Affiliated Taian City Central Hospital of Qingdao University, Taian, Shandong
2 shared publicationsRongbin Lv
Department of PET/CT, Affiliated Taian City Central Hospital of Qingdao University
2 shared publicationsAnning Li
Shandong Univ, Qilu Hosp, Dept Radiol, Jinan, Shandong, Peoples R China
1 shared publication
Latest Publications
- 20 January 2025
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 46 (4) , 347-355
Network topology and metabolic alterations in early- and mid-stage Parkinson’s disease: insights from fluorodeoxyglucose PET imaging
Objectives: Parkinson’s disease (PD) is a neurodegenerative disorder with distinct metabolic alterations in the brain, which are detectable via 18F-FDG PET. This study aims to delineate glucose metabolism patterns and network topology changes across early- and mid-stage PD patients. Methods: A total of 80 PD patients (Hoehn–Yahr stages 1–3) were retrospectively analyzed, including 40 early-stage and 40 mid-stage cases, along with 40 age-matched healthy controls. All participants underwent 18F-FDG PET imaging. The brain metabolic activity was quantified, and network topology was assessed using graph theory metrics. Statistical comparisons between PD stages and control groups were performed to identify significant differences in metabolic patterns and network alterations. Results: Early-stage PD patients exhibited hypermetabolism in regions such as the pons and thalamus, with significant differences in metabolic activity compared with controls. Mid-stage PD patients showed more extensive hypermetabolism in the pons, right cerebellum, and putamen, alongside hypometabolism in the cuneus and calcarine regions. Hub node connectivity analysis revealed decreased connectivity in temporal and occipital lobes for both stages, while the limbic and frontal lobes showed enhanced connectivity. Compared with early-stage PD, mid-stage PD had reduced connectivity in the limbic system but increased in the frontal and occipital lobes. Conclusions: 18F-FDG PET imaging reveals progressive metabolic disruptions and network changes in PD, offering potential biomarkers for disease staging and therapeutic targeting, while also aiding in the understanding of disease progression and guiding therapeutic interventions.
- 20 January 2025
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 46 (4) , 347-355
Network topology and metabolic alterations in early- and mid-stage Parkinson’s disease: insights from fluorodeoxyglucose PET imaging
Objectives: Parkinson’s disease (PD) is a neurodegenerative disorder with distinct metabolic alterations in the brain, which are detectable via 18F-FDG PET. This study aims to delineate glucose metabolism patterns and network topology changes across early- and mid-stage PD patients. Methods: A total of 80 PD patients (Hoehn–Yahr stages 1–3) were retrospectively analyzed, including 40 early-stage and 40 mid-stage cases, along with 40 age-matched healthy controls. All participants underwent 18F-FDG PET imaging. The brain metabolic activity was quantified, and network topology was assessed using graph theory metrics. Statistical comparisons between PD stages and control groups were performed to identify significant differences in metabolic patterns and network alterations. Results: Early-stage PD patients exhibited hypermetabolism in regions such as the pons and thalamus, with significant differences in metabolic activity compared with controls. Mid-stage PD patients showed more extensive hypermetabolism in the pons, right cerebellum, and putamen, alongside hypometabolism in the cuneus and calcarine regions. Hub node connectivity analysis revealed decreased connectivity in temporal and occipital lobes for both stages, while the limbic and frontal lobes showed enhanced connectivity. Compared with early-stage PD, mid-stage PD had reduced connectivity in the limbic system but increased in the frontal and occipital lobes. Conclusions: 18F-FDG PET imaging reveals progressive metabolic disruptions and network changes in PD, offering potential biomarkers for disease staging and therapeutic targeting, while also aiding in the understanding of disease progression and guiding therapeutic interventions.
- 8 November 2024
- Published by Elsevier in Clinical Radiology
- Vol. 80, 106746
MRI-based radiomics virtual biopsy for BCL6 in primary central nervous system lymphoma
- 8 November 2024
- Published by Elsevier in Clinical Radiology
- Vol. 80, 106746
MRI-based radiomics virtual biopsy for BCL6 in primary central nervous system lymphoma
- 6 July 2024
- Published by Elsevier in European Journal of Radiology
- Vol. 178, 111603
MRI-based radiomics signatures for preoperative prediction of Ki-67 index in primary central nervous system lymphoma
- 6 July 2024
- Published by Elsevier in European Journal of Radiology
- Vol. 178, 111603
MRI-based radiomics signatures for preoperative prediction of Ki-67 index in primary central nervous system lymphoma
- Open Access
- 13 February 2024
- Published by Georg Thieme Verlag KG in World Journal of Nuclear Medicine
- Vol. 23 (01) , 033-042
Predictive Value of Corrected 18F-FDG PET/CT Baseline Parameters for Primary DLBCL Prognosis: A Single-center Study
Objective The purpose of this study was to evaluate the prognostic significance of corrected baseline metabolic parameters in fluorodeoxyglucose positron emission tomography imaging (18F-FDG PET/CT) for 3-year progression-free survival (PFS) in patients with primary diffuse large B cell lymphoma (DLBCL). Patients and Methods Retrospective clinical and pathological data were collected for 199 patients of DLBCL diagnosed between January 2018 and January 2021. All patients underwent 18F-FDG PET/CT scans without any form of treatment. The corrected maximum standardized uptake value (corSUVmax), corrected mean standardized uptake value (corSUVmean), corrected whole-body tumor metabolic volume sum (corMTVsum), and corrected total lesion glycolysis of whole body (corTLGtotal) were corrected using the SUVmean in a 1-cm diameter mediastinal blood pool (MBP) from the descending thoracic aorta of patients. Kaplan–Meier survival curves and Cox regression were used to examine the predictive significance of corrected baseline metabolic parameters on 3-year PFS of patients. The incremental values of corrected baseline metabolic parameters were evaluated by using Harrell's C-indices, receiver operating characteristic, and Decision Curve Analysis. Results The multivariate analysis revealed that only the National Comprehensive Cancer Network (NCCN)-International Prognostic Index (IPI) and corMTVsum had an effect on 3-year PFS of patients (p < 0.05, respectively). The Kaplan–Meier survival analysis demonstrated significant differences in PFS between the risk groups classified by corSUVsum, corMTVsum, and corTLGtotal (log-rank test, p < 0.05). The predictive model composed of corMTVsum and corTLGtotal surpasses the predictive performance of the model incorporating MTVsum and TLGtotal. The optimal performance was observed when corMTVsum was combined with NCCN-IPI, resulting in a Harrell's C index of 0.785 and area under the curve values of 0.863, 0.891, and 0.947 for the 1-, 2-, and 3-year PFS rates, respectively. Conclusion The corMTVsum offers significant prognostic value for patients with DLBCL. Furthermore, the combination of corMTVsum with the NCCN-IPI can provide an accurate prediction of the prognosis. * These authors contributed equally to this work and retain the first authorship. Article published online: 13 February 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
- 13 February 2024
- Published by Georg Thieme Verlag KG in World Journal of Nuclear Medicine
- Vol. 23 (01) , 033-042
Open AccessPredictive Value of Corrected 18F-FDG PET/CT Baseline Parameters for Primary DLBCL Prognosis: A Single-center Study
Objective The purpose of this study was to evaluate the prognostic significance of corrected baseline metabolic parameters in fluorodeoxyglucose positron emission tomography imaging (18F-FDG PET/CT) for 3-year progression-free survival (PFS) in patients with primary diffuse large B cell lymphoma (DLBCL). Patients and Methods Retrospective clinical and pathological data were collected for 199 patients of DLBCL diagnosed between January 2018 and January 2021. All patients underwent 18F-FDG PET/CT scans without any form of treatment. The corrected maximum standardized uptake value (corSUVmax), corrected mean standardized uptake value (corSUVmean), corrected whole-body tumor metabolic volume sum (corMTVsum), and corrected total lesion glycolysis of whole body (corTLGtotal) were corrected using the SUVmean in a 1-cm diameter mediastinal blood pool (MBP) from the descending thoracic aorta of patients. Kaplan–Meier survival curves and Cox regression were used to examine the predictive significance of corrected baseline metabolic parameters on 3-year PFS of patients. The incremental values of corrected baseline metabolic parameters were evaluated by using Harrell's C-indices, receiver operating characteristic, and Decision Curve Analysis. Results The multivariate analysis revealed that only the National Comprehensive Cancer Network (NCCN)-International Prognostic Index (IPI) and corMTVsum had an effect on 3-year PFS of patients (p < 0.05, respectively). The Kaplan–Meier survival analysis demonstrated significant differences in PFS between the risk groups classified by corSUVsum, corMTVsum, and corTLGtotal (log-rank test, p < 0.05). The predictive model composed of corMTVsum and corTLGtotal surpasses the predictive performance of the model incorporating MTVsum and TLGtotal. The optimal performance was observed when corMTVsum was combined with NCCN-IPI, resulting in a Harrell's C index of 0.785 and area under the curve values of 0.863, 0.891, and 0.947 for the 1-, 2-, and 3-year PFS rates, respectively. Conclusion The corMTVsum offers significant prognostic value for patients with DLBCL. Furthermore, the combination of corMTVsum with the NCCN-IPI can provide an accurate prediction of the prognosis. * These authors contributed equally to this work and retain the first authorship. Article published online: 13 February 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India